Health

Fireside Project’s New Equity Initiative Expands Psychedelic Support Services

Since launching last year, Fireside Project has supported more than 1,700 people on its Psychedelic Peer Support Line, and now the organization is promoting more inclusion and diversity.

Ketamine Could Treat Alcohol Use Disorder, Study Shows

Ketamine coupled with psychotherapy shows promise as a treatment option for alcohol use disorder in a Phase 2 clinical trial, adding momentum to the use of psychedelics for treat ing substance abuse.

Effects of Psilocybin-Assisted Therapy for Depression Shown to Last for a Year

The Johns Hopkins study is the longest follow-up to date and indicates that therapy protocols and other factors are important to positive treatment outcomes.

Psychedelics Open Opportunity to Study Synesthesia

The pairing of sound and color is the most common form of synesthesia on psychedelics, researchers found.

What Research Doesn’t Tell Us About Older Psychedelic Users

The risks psychedelics may hold for older generations are still unknown, but the rewards could include treating pain, processing grief and trauma, and helping women in menopause.

New Research Probes Psilocybin’s Effect on Suicidality

A review of psilocybin therapy for terminal patients becomes more relevant in light of recent research from Compass Pathways.

Psychedelic-Assisted Therapy on the Rise in VA Hospitals

Veterans Administration medical centers across the country are creating and deploying protocols for psychedelic therapy.

New York City Opens First U.S. Overdose Prevention Centers 

Amid record overdose deaths, New York City has opened the first overdose prevention centers despite mixed signals from the Biden Administration.

New Survey Suggests Psychedelics Could Help Heal the Complex Trauma of Child Abuse

Participants who had experienced childhood abuse and used psychedelics with therapeutic intent reported feeling less internalized shame.

Ketamine Users Can Help Ensure Safety with DanceSafe’s Testing Kit

The new kit uses the Morris reagent, the only known chemical that reacts to the presence of ketamine.